5nance5nance
5nance5nance
HomeScreens
LOGINGET FREE ACCOUNT

Sai Life Sciences Ltd.

•
sailife.comBSE: 544306NSE: SAILIFE
Market Cap₹ 33,669 Cr.
Current Price
High / Low₹ 1,697 / 784
Stock P/E93.1
Book Value₹ 120
Price to Book8.29
Dividend Yield0.00 %
ROCE21.0 %
ROE15.2 %
Face Value₹ 1

Add ratio to table

ABOUT

AI Sector View

AI GENERATED

Healthcare

Buy

This stance relies on proxies and positioning because no direct pharma-export or healthcare operating series exists in the dataset. The depreciated currency at 95.23 (Sep/26) can support export earnings, inflation at 4.45% (Jul/26) is manageable for a defensive sector, and consumer spending remains large at INR 44743 billion (Jun/26). Strong FPI inflow of INR 10620 crore over 3 months to 2026-08-31 from INR -11381 crore in the prior 3 months adds a real sector-specific tailwind, but confidence stays capped because the fundamental drivers are indirect proxies.

Confidence
50%
View full sector analysis →

PROS

  • Company has delivered good profit growth of 41.7% CAGR over last 5 years
  • Company is almost debt free
  • Company has delivered good sales growth of 23.6% CAGR over last 5 years
  • Operating margins have improved to 27.7% from 16.2%
  • Company has consistently been profitable over the last 5 years
  • Strong cash generation - operating cash flow backs reported profits (CFO/PAT 1.80x)

CONS

  • Promoter holding has decreased over last 2 years: -3.4pp
  • Equity base is being diluted - shares outstanding up 20.2%
  • Stock is trading at 8.3x its book value
  • Though reporting repeated profits, the company pays out little dividend (0.0%)
  • Rich enterprise valuation - EV/EBITDA of 30.1x

* The pros and cons are machine generated based on quantitative rules.

Peer comparison

HealthcareHealthcarePharmaceuticals & Drugs
Part ofNIFTY PHARMANIFTY500MOMENTM50NIFTY TOTAL MKTNIFTY SMLCAP 50NIFTY 500
S.No.Name
1.SUNPHARMA1842.0036.54441957.500.872901.2326.5315299.8810.9819.1128.81
2.DIVISLAB9326.0084.64247576.000.32902.0065.503080.0027.8021.5140.75
3.TORNTPHARM4975.0086.76189233.010.76566.003.284921.0057.3219.2733.81
4.ZYDUSLIFE1119.5024.74111670.550.09990.20-34.908017.0023.9721.3924.54
5.CIPLA1365.0032.72110272.680.95785.55-39.187119.284.1316.0016.73
6.LAURUSLABS1970.3597.37106460.420.10362.07123.942026.3129.1018.2031.50
7.DRREDDY1161.0030.0796906.380.69435.60-69.108099.80-5.2113.7510.63
8.AUROPHARMA1675.4525.9796401.690.241032.0325.229150.3517.4412.7620.54
9.LUPIN2096.0017.3495842.920.861416.9816.018276.8934.2828.8629.59
10.MANKIND2277.0046.0494050.370.04574.0929.124030.5912.8913.2426.30
11.GLENMARK2416.9037.9468210.880.10482.83927.884018.4831.3520.3520.03
12.SAILIFE1585.2093.0733668.730.0073.2821.22554.2911.6620.9726.70
Detailed Comparison with:

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
384439280396440580496537556602554
287315254293320422375392369426460
Operating Profit961252610212015812114618817794
OPM %25.11%28.38%9.33%25.84%27.23%27.19%24.36%27.13%33.76%29.32%17.04%
11381091010150164
Interest2321212123111291088
Depreciation3131313634373840444546
Profit before Tax5376-1855721198111213413998
Tax %25.20%26.21%25.29%24.96%24.84%25.70%25.13%25.18%25.18%25.13%25.20%
Net Profit00005488608410010473
2.193.10-0.742.222.894.242.904.014.774.933.46

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
4455266957267608701,2171,4651,6952,1922,250
3674285205585937451,0481,1781,2871,5851,646
Operating Profit7899176168167125169287408608605
OPM %17.48%18.75%25.25%23.11%22.02%14.36%13.88%19.60%24.07%27.71%26.87%
19961827282829376635
Interest1217242233538188784135
Depreciation21274455809099119139167175
Profit before Tax6463113109821016109228466483
Tax %25.54%33.02%35.02%30.03%25.41%35.78%39.12%24.19%25.28%25.16%25.17%
Net Profit484273766161083170349362
EPS33.1029.6251.5446.4635.440.340.5546.888.1616.48—
Dividend Payout %0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%—

COMPOUNDED SALES GROWTH

10 Years:
18%
5 Years:
24%
3 Years:
22%

COMPOUNDED PROFIT GROWTH

10 Years:
26%
5 Years:
42%
3 Years:
227%

STOCK PRICE CAGR

10 Years:
—
5 Years:
—
3 Years:
—
1 Year:
82%

RETURN ON EQUITY

10 Years:
10%
5 Years:
7%
3 Years:
12%
Last Year:
15%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions

No bonus data found

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital14141616171818182121
3053487007728388528619462,1022,458
198229288335665944899829293218
Trade Payables4795107143138199209138323285
8583104144158146193377470728
Total Liabilities6487691,2151,4101,8172,1592,1792,3093,2093,710
2723073736417539721,0371,1801,4881,815
Capital Work in Progress91411691194189151107124270
00000022251
447344447612714087119151
0000000256355374
Cash & Bank1517250987613086159464111
308359431536717741763518657939
Total Assets6487691,2151,4101,8172,1592,1792,3093,2093,710

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
3860157135-21113223263314509
Cash from Investing-69-62-158-262-260-104-102-192-537-395
Cash from Financing4412268-429572-201-95301-124
-6-1239-150-173-83-2579-10

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026

Shareholding Pattern

Numbers in percentages

Mar 2023Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
37.9135.2435.2435.1735.1534.9434.7034.6134.53
0.007.6311.7212.3614.5722.5021.4121.1719.65
0.005.6111.9513.2621.6429.9231.4131.5432.71
Government0.000.000.000.000.000.000.000.000.00
56.1051.5241.0939.2128.6412.6512.4912.6813.11

Documents

Corporate disclosures, annual reports, credit ratings, and concall transcripts

2026-09-04
Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-04 - Sai Life Sciences Limited has informed the Exchange about Schedule of meet

2026-09-04
Analysts/Institutional Investor Meet/Con. Call Updates

2026-09-04 - Sai Life Sciences Limited has informed the Exchange about Schedule of meet

2026-09-01
ESOP/ESOS/ESPS

2026-09-01 - Sai Life Sciences Limited has informed the Exchange regarding Allotment of 80600 Shares.

2026-08-26
Copy of Newspaper Publication

2026-08-26 - Sai Life Sciences Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-25
Updates

2026-08-25 - Sai Life Sciences Limited has informed the Exchange regarding 'Web Link Letters to Shareholders'.

2026-08-25
Shareholders meeting

2026-08-25 - Sai Life Sciences Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on September 17, 2026

2026-08-24
Copy of Newspaper Publication

2026-08-24 - Sai Life Sciences Limited has informed the Exchange about Copy of Newspaper Publication

2026-08-24
Updates

2026-08-24 - Sai Life Sciences Limited has informed the Exchange regarding 'Information relating to 27th Annual General Meeting (AGM) and Cut-off date for e-voting.'.

2026-08-12
Analysts/Institutional Investor Meet/Con. Call Updates

2026-08-12 - Sai Life Sciences Limited has informed the Exchange about Transcript

News

Recent coverage and analyst commentary for SAILIFE

Loading news…

🤖

AI Stock Analyst

Sai Life Sciences Ltd.

🔒

Sign in to Chat with AI

Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.

✨ Sign In to Chat

Free 5nance Account

5nance5nance

Stock analysis and screening tool

5nanceAI © 2020-2026

Made with ❤️ in India.

Data provided by Accord Fintech

Terms & Privacy.

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nance5nance

Product

PremiumWhat's new?Learn

Team

About usSupport

Theme

5nanceAI © 2020-2026

Data provided by Accord Fintech

Made with ❤️ in India.

HomeScreens
Login